TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
900
|
746
|
826 |
Financial expenses |
1
![]() |
1
![]() |
1 |
Earnings before taxes |
344
|
446
|
122 |
EBITDA |
212
|
-47
|
116 |
Total assets |
1,379
|
1,230
|
739 |
Current assets |
972
|
875
|
397 |
Current liabilities |
702
|
463
|
198 |
Equity capital |
432
|
604
|
455 |
- share capital |
33
|
36
|
37 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
31.3%
|
49.1%
|
61.6% |
Turnover per employee |
900
|
746
|
826 |
Profit as a percentage of turnover |
38.2%
|
59.8%
|
14.8% |
Return on assets (ROA) |
25.0%
|
36.3%
|
16.6% |
Current ratio |
138.5%
|
189.0%
|
200.5% |
Return on equity (ROE) |
79.6%
|
73.8%
|
26.8% |
Change turnover |
215
|
-65
|
79 |
Change turnover % |
31%
|
-8%
|
11% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.